Recombinant Human Transmembrane protein 116 (TMEM116)

What is the molecular structure and basic characteristics of human TMEM116?

TMEM116 (Transmembrane Protein 116) is a membrane-spanning protein with a molecular weight of approximately 23 kDa . The full-length human TMEM116 protein consists of 245 amino acids . Structural analysis suggests it contains multiple transmembrane domains typical of integral membrane proteins. The protein sequence includes hydrophobic regions consistent with membrane-spanning segments that anchor the protein within cellular membranes.

For experimental applications, recombinant human TMEM116 can be expressed in wheat germ expression systems, yielding full-length protein (amino acids 1-245) suitable for various research applications . The protein contains specific motifs that suggest potential roles in ion transport across cellular membranes, though detailed structural studies using crystallography or cryo-EM remain limited in the current literature.

What cellular localization patterns does TMEM116 exhibit in human tissues?

TMEM116 displays distinct tissue-specific localization patterns that provide insights into its potential physiological functions. Immunohistochemical analyses reveal positive membranous staining in multiple human tissues:

• Seminiferous duct cells in testis tissue

• Glandular cells in gastrointestinal tissue

• Glandular cells in stomach tissue

• Glandular cells in fallopian tube tissue

At the subcellular level, immunofluorescence studies in the human A-431 cell line show that TMEM116 localizes predominantly to the nucleus but is notably absent from nucleoli. The protein does not appear to associate significantly with cytoskeletal elements such as microtubules . This nuclear localization is somewhat unexpected for a transmembrane protein and suggests potential multifunctional roles beyond typical membrane-associated functions.

When designing experiments to study TMEM116 localization, researchers should consider using multiple detection methods and cell types to comprehensively map its distribution patterns.

What are the optimal protocols for detecting and studying TMEM116 in experimental settings?

Several complementary approaches can be employed to study TMEM116, each with specific methodological considerations:

Immunohistochemistry (IHC-P):

• Recommended antibody: Rabbit Polyclonal TMEM116 antibody (e.g., ab122663)

• Optimal concentration: 1-4 μg/ml for tissue sections

• Detection method: DAB or fluorescence-based visualization

• Controls: Include negative controls (omitting primary antibody) and positive controls (tissues known to express TMEM116, such as testis or stomach)

Immunocytochemistry/Immunofluorescence (ICC/IF):

• Cell preparation: Fixation with 4% paraformaldehyde followed by permeabilization

• Antibody concentration: 1-4 μg/ml

• Counterstaining: Consider DAPI for nuclear visualization to confirm nuclear localization

• Imaging: Confocal microscopy recommended for precise subcellular localization

Western Blotting (WB):

• Sample preparation: Ensure complete membrane protein extraction with appropriate detergents

• Protein loading: 20-50 μg of total protein per lane

• Recombinant protein controls: Consider using ab164800 as a positive control

• Expected band size: Approximately 23 kDa

ELISA Applications:

• Recombinant TMEM116 (ab164800) can be used for standard curve generation

• Sensitivity optimization: Titrate antibody concentrations to determine optimal detection range

• Sample types: Cell lysates, tissue homogenates, or serum depending on experimental question

How can researchers effectively express and purify recombinant TMEM116 for functional studies?

Producing recombinant TMEM116 requires careful consideration of expression systems and purification strategies:

Expression Systems Comparison:

Purification Protocol Recommendations:

• For wheat germ-expressed TMEM116 (as in ab164800) :

  • Cell lysis under non-denaturing conditions

  • Affinity chromatography using appropriate tags (His or GST)

  • Size exclusion chromatography for final purification

  • Buffer optimization to maintain membrane protein stability

  • Consider adding stabilizing agents like glycerol or specific detergents

• Quality control measures:

  • SDS-PAGE with Coomassie staining to confirm size and purity

  • Western blot verification with anti-TMEM116 antibodies

  • Mass spectrometry for sequence confirmation

  • Functional assays to verify biological activity

What is currently known about the function of TMEM116 in cellular homeostasis?

Current evidence suggests TMEM116 plays roles in cellular ion transport and homeostasis, though detailed mechanistic studies remain limited . The protein's membrane-spanning domains are consistent with potential functions in:

• Ion transport regulation: TMEM116 may facilitate the movement of specific ions across cellular membranes, contributing to electrochemical gradient maintenance . This hypothesis is supported by structural features including hydrophobic transmembrane segments consistent with ion channel components.

• Cellular homeostasis maintenance: The expression pattern in secretory and absorptive tissues (stomach, intestine) suggests potential roles in maintaining cellular ionic balance . Researchers investigating this function should consider flux assays with ion-specific indicators or electrophysiological approaches.

• Nuclear functions: The unexpected nuclear localization observed in some cell types suggests potential roles beyond typical membrane transport, possibly in signaling or regulatory pathways . This dual localization pattern warrants further investigation using cell fractionation studies combined with functional assays.

Methodological approaches to investigate these functions include:

• Ion flux assays using fluorescent indicators

• Patch-clamp electrophysiology

• Knockout/knockdown studies followed by homeostasis challenge experiments

• Protein-protein interaction screens to identify functional partners

How does TMEM116 interact with other proteins and cellular pathways?

While comprehensive interaction networks for TMEM116 remain to be fully characterized, correlation analyses from gene expression studies provide initial insights into potential functional associations :

Positive correlations have been observed between TMEM116 and several other membrane proteins, including:

• TMEM97 (involved in cholesterol homeostasis)

• TMEM17, TMEM22, TMEM48, TMEM158, TMEM206, and TMEM213

These correlations suggest potential functional relationships or co-regulation mechanisms that warrant further investigation through:

• Co-immunoprecipitation followed by mass spectrometry to identify direct binding partners

• Proximity labeling approaches (BioID or APEX) to map the protein's microenvironment

• Co-expression studies using dual fluorescent reporters

• Functional assays examining the impact of TMEM116 perturbation on associated proteins

Researchers investigating TMEM116 interactions should design experiments that can distinguish between direct physical interactions and indirect functional associations, possibly through a combination of in vitro binding assays and cellular co-localization studies.

What is the expression profile of TMEM116 in cancer and other pathological conditions?

TMEM116 shows altered expression in several pathological conditions, most notably in cancer:

Head and Neck Squamous Cell Carcinoma (HNSCC):

• TMEM116 is significantly downregulated in HNSCC tumor samples compared to normal tissue

• This downregulation pattern contrasts with some other TMEM family members (e.g., ANO1, TMEM17, TMEM48) that show upregulation in HNSCC

• The expression changes appear to be tissue-specific and may vary based on tumor characteristics

Essential Hypertension:

• Transcriptome-wide association studies have identified TMEM116 as a potential susceptibility gene for essential hypertension

• The mechanistic link requires further investigation but may relate to TMEM116's potential role in ion transport

For researchers studying TMEM116 in disease contexts, methodological considerations should include:

• Comparison of expression levels across multiple disease stages and subtypes

• Correlation with clinical outcomes and treatment responses

• Integration with other molecular markers for comprehensive profiling

• Functional validation in disease-relevant cell or animal models

How can TMEM116 expression analysis be integrated into biomarker research?

While TMEM116 alone may not serve as a standalone biomarker, its integration into multi-gene panels shows promise for several applications:

Methodological approach for biomarker development:

• Context-specific expression analysis:

  • Compare TMEM116 expression across normal, dysplastic, and malignant tissues

  • Stratify by relevant clinical factors (HPV status, tumor grade, anatomical site)

  • Correlate with treatment response and patient outcomes

• Multi-gene panel integration:

  • Consider TMEM116 alongside other dysregulated TMEM family members

  • For HNSCC specifically, consider analyzing TMEM116 in conjunction with ANO1, TMEM156, TMEM173, and TMEM213, which have shown correlation with clinical status and immune responses

  • Develop weighted scoring algorithms that account for the relative contribution of each gene

• Validation strategies:

  • Cross-platform validation (RNA-seq, qPCR, protein-level detection)

  • Independent cohort validation

  • Functional studies to establish biological relevance

Researchers should be cautious about technical variables that might affect TMEM116 detection and consider the biological context when interpreting expression changes.

How can TMEM116 be targeted for functional manipulation in experimental systems?

Advanced research on TMEM116 requires precise manipulation of its expression and function:

Gene Editing Approaches:

• CRISPR-Cas9 knockout strategies:

  • Target early exons to ensure complete loss of function

  • Design multiple guide RNAs to increase efficiency

  • Include rescue experiments with recombinant protein to confirm specificity

• Knockin modifications:

  • Consider epitope tagging at N- or C-terminus for improved detection

  • Introduce point mutations to study specific functional domains

  • Create conditional alleles for tissue-specific manipulation

RNA Interference:

• siRNA targeting specific TMEM116 regions

• shRNA for stable knockdown studies

• Antisense oligonucleotides for in vivo applications

Overexpression Systems:

• Inducible expression systems to control timing and level

• Viral vectors for efficient delivery to difficult-to-transfect cells

• Domain-specific constructs to dissect protein function

Functional Modulation:

• Small molecule screening to identify potential inhibitors or activators

• Antibody-based functional blocking approaches

• Peptide mimetics targeting specific protein interfaces

For each approach, careful validation of manipulation efficiency and specificity is essential through:

• qPCR and western blot confirmation

• Phenotypic characterization

• Off-target effect assessment

• Dose-response relationships

What are the most promising future research directions for TMEM116?

Based on current knowledge gaps and preliminary findings, several research directions show particular promise:

• Structural biology approaches:

  • Cryo-EM or X-ray crystallography to resolve TMEM116 structure

  • Molecular dynamics simulations to understand conformational changes

  • Structure-guided functional domain mapping

• Systems biology integration:

  • Multi-omics approaches combining transcriptomics, proteomics, and metabolomics

  • Network analysis to position TMEM116 within broader cellular pathways

  • Machine learning applications to predict functional associations

• Translational research avenues:

  • Development of TMEM116-targeted therapeutics for relevant pathologies

  • Biomarker validation in larger clinical cohorts

  • Patient-derived models to study personalized responses

• Evolutionary biology perspectives:

  • Comparative analysis across species to identify conserved functions

  • Adaptive evolution studies to understand specialized roles

  • Paralog functional divergence investigation

• Technological innovations:

  • Development of specific tools for TMEM116 detection and manipulation

  • High-throughput screening approaches to identify interactors

  • Advanced imaging techniques to track dynamics in living cells

Researchers pursuing these directions should emphasize interdisciplinary approaches and consider both basic mechanistic studies and potential clinical applications.

What are the common challenges in TMEM116 research and how can they be addressed?

Researching transmembrane proteins like TMEM116 presents several technical challenges:

Challenge: Antibody specificity and validation

• Solution: Utilize multiple antibodies targeting different epitopes

• Implementation: Compare staining patterns across antibodies and validate with knockout controls

• Methodological check: Preabsorption with recombinant TMEM116 protein to confirm specificity

Challenge: Protein solubilization and extraction

• Solution: Optimize detergent conditions specifically for TMEM116

• Implementation: Test panel of detergents (CHAPS, DDM, Triton X-100) at various concentrations

• Methodological check: Western blot to confirm extraction efficiency

Challenge: Distinguishing membrane vs. nuclear pools

• Solution: Rigorous subcellular fractionation

• Implementation: Differential centrifugation with marker verification

• Methodological check: Immunofluorescence correlation with biochemical fractionation

Challenge: Functional assay development

• Solution: Establish clear readouts based on hypothesized functions

• Implementation: Ion flux assays, interaction screens, or phenotypic analyses

• Methodological check: Include positive controls with known membrane transporters

Challenge: Low expression levels in some systems

• Solution: Enrichment strategies and sensitive detection methods

• Implementation: Consider immunoprecipitation before analysis

• Methodological check: qPCR validation of expression levels

How should researchers interpret contradictory findings about TMEM116 in the literature?

When facing conflicting reports about TMEM116 function or expression, researchers should consider:

• Methodological differences assessment:

  • Compare detection methods (antibody-based vs. transcript-based)

  • Evaluate sample processing protocols

  • Consider quantification and normalization approaches

• Biological context variables:

  • Cell/tissue type specificity

  • Disease state and progression stage

  • Microenvironmental conditions

  • Species differences if comparing across organisms

• Technical resolution approach:

  • Direct side-by-side comparison using standardized protocols

  • Utilization of multiple complementary techniques

  • Collaboration with groups reporting conflicting results

• Interpretation framework:

  • Consider TMEM116 might have context-dependent functions

  • Look for conditional factors that might explain differences

  • Develop testable hypotheses that could reconcile contradictions

Researchers should approach contradictions as opportunities to discover new regulatory mechanisms or context-dependent functions, rather than simply dismissing conflicting reports.